Mergermarket: CuraCell plans EUR 25m round to fund cancer cell therapy
CuraCell CEO Jonas Batelson recently spoke to Jonathan Smith, a reporter for Mergermarket, about the companies plans for its next funding round to allow its TIL therapy trials to proceed.
